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Background: A variety of biological and psychosocial factors are associated with
women’s sexual health in midlife and older age. Evidence suggests a decline in sexual
functioning in the context of aging and the menopausal transition, including changes
in sexual desire, arousal, lubrication, orgasm, pain, and/or contentment. However,
not all women in midlife and older age experience such a decline, and it remains
unclear how the endocrine environment and psychosocial aspects contribute to the
maintenance of healthy sexual functioning. Therefore, the aim of this study was to
examine psychobiological predictors of sexual functioning in healthy middle-aged and
elderly females.
Methods: A total of 93 healthy, sexually active women aged 40–73 years completed
a battery of validated psychosocial questionnaires, including measures of sexual
functioning (Female Sexual Function Index) and of protective psychological traits and
interpersonal variables. The steroid hormones estrogen, testosterone, progesterone
and dehydroepiandrosterone sulfate were determined in saliva samples, while
follicle-stimulating hormone, luteinizing hormone and sex hormone-binding globulin
were determined in dried blood spots. The findings were statistically adjusted for
multiple testing.
Results: Age and postmenopausal status were negatively associated with overall sexual
functioning, arousal, and lubrication. Regression analyses revealed that relationship
satisfaction, emotional support, self-esteem, optimism, and life satisfaction each
significantly predicted overall sexual functioning or specific aspects of sexual functioning,
including arousal, contentment, orgasm, and pain (all p < 0.029). For desire and
lubrication, no associations were found with the tested psychosocial factors. In terms
of steroid hormones, testosterone was positively linked to orgasm (p = 0.012). In
this sample, 79.6% reported to have healthy sexual functioning according to the
questionnaires’ cutoff. Younger age (OR = 0.911, 95% CI 0.854–0.970, p = 0.004) and
a higher level of emotional support (OR = 1.376, 95% CI 1.033–1.833, p = 0.029) were
associated with the presence of healthy sexual functioning.
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Discussion: Although aging and menopause negatively affected aspects of sexual
functioning, the accompanying endocrine correlates were not predictive for sexual
functioning in this healthy sample of middle-aged and older females. Instead, our
findings suggest that sexual functioning is highly dependent on psychosocial aspects
related to well-being. Accordingly, personality traits such as optimism, and interpersonal
aspects such as emotional support and relationship satisfaction were identified as
important predictors of sexual functioning.
Keywords: sexual functioning, female sexuality, women’s health, midlife and older age, biopsychosocial factors
INTRODUCTION
As populations are aging rapidly all over the world, there has
been a growing interest in healthy aging and associated factors.
One important aspect that is often overlooked or treated as
taboo in aging populations is sexual health (Lusti-Narasimhana
and Beard, 2013), even though sexuality is considered to be a
fundamental part of being human and a central component of
general health (Graugaard, 2017). According to the definition of
the World Health Organization, sexual health refers to “a state
of physical, emotional, mental, and social well-being in relation
to sexuality, and not merely the absence of disease, dysfunction,
or infirmity” (World Health Organization, 2006, p. 5). There is
considerable knowledge concerning the positive association of
sexual health with general well-being and health-related quality of
life (Davison et al., 2009; Lee et al., 2016; Greenberg et al., 2017).
Historically, it was assumed that sexuality and its associated
physical response does not differ between men and women
(Masters and Johnson, 1966). Accordingly, physical sexual
response is characterized by the linear progression from
excitement, to plateau, orgasm, and finally resolution. However,
this classical model was frequently criticized due to its sole focus
on the physical (genital) response and was therefore extended
with the aspect of sexual desire preceding the excitement
phase (Kaplan, 1979). Despite this adaptation, it has been
debated whether this linear model of sexual response adequately
reflects women’s sexual experience. Basson (2001) proposed an
alternative circular model, which specifically refers to the female’s
sexual response. This model emphasizes the importance of
emotional intimacy (as a result of a satisfying sexual experience)
for future willingness to engage in sexual activity. According
to the fifth edition of the Diagnostic and Statistical Manual of
Mental Disorders (DSM-5), sexual functioning encompasses a
complex interplay of biological, psychological, and sociocultural
factors and can be significantly disturbed when a person’s ability
to respond sexually or experience sexual pleasure is impaired
(American Psychiatric Association, 2013).
Women’s sexual functioning can vary, or permanently change,
across the life course, especially in the context of reproductive
events and aging (Clayton and Harsh, 2016). There is a growing
body of research investigating sexual functioning in middle-aged
women experiencing the menopausal transition. Most of these
studies have found a decline in sexual functioning in association
with the menopausal transition (Dennerstein et al., 2003; Avis
et al., 2017), with hormonal changes and associated vaginal
dryness assumed to be the key factors in this decline. Moreover,
studies have also looked at the aging process independently of
menopausal status. Sexual functioning is thought to decline with
increasing age. This may be due to an overall decline in general
health as women age, physical changes or medical conditions
(Clayton and Harsh, 2016). The age-associated decline in sexual
functioning has been underpinned by prevalence studies of sexual
dysfunction in middle and older age. For example, Nicolosi
et al. (2004) assessed prevalence rates of sexual dysfunction
in approximately 14,000 women aged 40–80 years from 29
countries. More than 65% of all women reported to have engaged
in sexual activity in the past year. Among these, 38% reported
having sexual intercourse more than once a week. The most
prevalent sexual dysfunction in middle-aged and elderly women
was a lack of sexual interest (21%), followed by inability to reach
orgasm (16%) and lubrication difficulties (16%), no pleasure
during intercourse (15%), and pain during intercourse (10%).
A clear age pattern was detected, with increased prevalence
rates with higher age (Nicolosi et al., 2004). According to
an elaborated overview of the worldwide prevalence of sexual
dysfunction provided by McCabe et al. (2016), the prevalence
rates for low levels of female sexual desire vary between 17 and
55%. Negative age effects were observed after the age of 60,
when the prevalence rates mostly range between 40 and 50%.
Arousal difficulties have often been operationalized as lubrication
insufficiencies, with varying prevalence rates of 21 to 28%. The
prevalence of orgasmic dysfunction varies between 16 and 37%.
Pain during sexual activity seems to be less prevalent in the
general population, ranging from 1 to 27% across various studies
(McCabe et al., 2016).
In sum, sexual dysfunction seems to increase in midlife
and older age, including changes in sexual desire, arousal,
lubrication, orgasm, pain, and/or contentment. However, there
is a high numerical variability across different studies and
countries, and there are some methodological issues which limit
the generalizability of the findings (Hayes and Dennerstein,
2005). Furthermore, there is no consensus regarding the aspects
of sexual functioning that change with advancing age. It
is important to acknowledge, however, that not all women
in midlife and older age experience a decline in sexual
functioning. In a study by Trompeter et al. (2012), most of
the surveyed sexually active women aged between 40 and
99 years reported frequent arousal, lubrication, and orgasm,
even if sexual desire was low. Additionally, sexual satisfaction
was higher in older women and was not associated with sexual
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activity. Lonnèe-Hoffmann et al. (2014) found similar results,
demonstrating no significant changes in sexual functioning
in women who maintained their sexual activity from early
to late postmenopause. These and other studies reveal that
sexual functioning does not necessarily worsen over the course
of aging and that research to date has mainly focused on
sexual dysfunction and negative aspects of sexuality among
elderly women (Lusti-Narasimhana and Beard, 2013). So far,
studies focusing on sexual health and positive aspects of sexual
functioning are sparse. A focus on sexual function rather
than dysfunction might be a more favorable approach in the
investigation of females’ sexual health. Insights into factors
associated with the maintenance of healthy sexual functioning
could potentially be of considerable benefit in terms of positive
health research.
As reflected in the WHO definition of sexual health, which
takes various dimensions into consideration and emphasizes
the role of well-being (World Health Organization, 2006),
sexual functioning should be defined positively and within
a biopsychosocial framework (Graugaard, 2017). Such a
perspective on sexual health in midlife and older age has been
established in the past few years (Conklin, 2017). A central
issue in the investigation of female sexual functioning is
the importance of other factors besides menopausal status
and age (e.g., Dennerstein et al., 2003). Psychosocial factors,
particularly psychological and interpersonal variables, seem
to play a crucial role in middle-aged and elderly women’s
sexual functioning (DeLamater and Karraker, 2009; Thomas
and Thurston, 2016). As presented in Figure 1, biological
determinants include, among other factors, age, menopausal
status, and hormonal changes related to menopause and
aging (Fiacco et al., 2018). In particular, sex steroids can
exert an impact on sexual functioning due to the fluctuations
which occur with aging and in the context of the menopausal
transition (Clayton and Harsh, 2016). Estradiol (E2) is the
best-examined sex steroid with regard to sexual functioning
in middle and older age. E2 levels show a sharp decline
during the menopausal transition, causing vaginal atrophy,
dryness and irritation, which may indirectly lead to decreased
sexual desire, arousal, and response (Wierman et al., 2010).
Moreover, androgens also seem to be associated with female
FIGURE 1 | Biopsychosocial model of female sexual health in midlife and
older age: biological, psychological, and interpersonal factors potentially
contributing to healthy sexual functioning.
sexual functioning. Testosterone (T) is the sex steroid which
is assumed to primarily influence sexual desire and motivation
(Bachmann and Leiblum, 2004; Wåhlin-Jacobsen et al., 2015).
However, the role of estrogens and androgens in relation
to female sexual functioning is highly controversial, since
findings are inconsistent and many studies did not report any
associations (Meston and Frohlich, 2000; Wierman et al., 2010).
For dehydroepiandrosterone sulfate (DHEA-S), which is the
most abundant sex steroid in females and an androgen precursor,
mostly positive associations with sexual functioning have been
reported (e.g., Davis et al., 2005). Little attention has been
paid to progesterone (P), follicle-stimulating hormone (FSH),
luteinizing hormone (LH), and sex hormone-binding globulin
(SHBG) in relation to female sexual functioning (Dennerstein
et al., 2005; Randolph et al., 2015; Worsley et al., 2016). To
conclude, more research is required in order to further examine
the contribution of sex steroids to women’s sexual functioning in
midlife and older age, and non-hormonal factors also need to be
taken into account.
As illustrated in Figure 1, psychological factors determining
sexual functioning may include good mental health (absence
of psychiatric conditions), specific psychological factors related
to well-being such as self-esteem or life satisfaction, and
protective personality traits. Psychiatric disorders constitute a
risk factor for female sexual dysfunction (Basson and Gilks,
2018), with depression and anxiety in particular showing
negative associations with sexual functioning (Althof et al.,
2005). Therefore, the absence of mental disorders such as
depression or anxiety may be protective for female sexual
health. Another psychological factor related to subjective well-
being that may have a positive impact on sexual functioning
is general life satisfaction. To date, only a small number of
studies have pointed out the relevance of life satisfaction for
sexual functioning in women (Woloski-Wruble et al., 2010;
Stephenson and Meston, 2015). Other studies have found a
high level of self-esteem to be a positive psychological factor in
female sexuality (Goodson et al., 2006; Rehbein-Narvaez et al.,
2006). Additionally, personality traits seem to be significant
for sexual health: A recent meta-analysis linking the Big Five
personality traits (McCrae and John, 1992) to sexual health
showed that a high level of extraversion was associated with
fewer symptoms of sexual dysfunction and a higher frequency
of sexual activity (Allen and Walter, 2018). Moreover, a higher
degree of extraversion was also found to be related to greater
sexual satisfaction (Allen and Desille, 2017) and to a higher
level of orgasmic frequency and overall sexual functioning
(Harris et al., 2008; Crisp et al., 2015).
Finally, besides biological and psychological determinants
of sexual functioning in midlife and older age, interpersonal
factors are crucial in the investigation of female sexual health
(Figure 1). First, the availability of a partner is an important
factor for the engagement in sexual activity and therefore sexual
functioning (DeLamater and Karraker, 2009). If they have a
partner, the majority of middle-aged and older women remain
sexually active (Thomas et al., 2015). The general satisfaction with
one’s partner or quality of communication in the relationship
are crucial for females in order to experience satisfying sexuality
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(Byers, 2005; Thomas and Thurston, 2016). Social support
from one’s partner may be another interpersonal factor which
affects sexuality due to its health-promoting effects (Uchino,
2006), but this has not yet been investigated in the context
of women’s aging. Finally, the partner’s physical or mental
health status may have an impact on females’ sexual functioning
(DeLamater and Karraker, 2009).
To summarize, it can be stated that first, female sexuality
in midlife and older age has often been studied in terms
of dysfunction and risk factors. Little attention has been
given to factors that may predict female sexual health in
midlife and older age. Hence, the present study focused on
aspects of sexual functioning instead of dysfunction, and on
associated protective factors. Furthermore, we investigated
exclusively healthy women, since studies with a solely healthy
female sample are scarce. Second, a biopsychosocial approach
that simultaneously considers biological, psychological, and
interpersonal factors should be applied when investigating
female sexual functioning. The questions of what the most
important determinants of sexual health in midlife and older
age are, and how psychosocial aspects and the endocrine
environment in these stages of life contribute to the maintenance
of healthy sexual functioning, have not been investigated
extensively. Therefore, the aim of this study was to examine
psychobiological predictors of sexual functioning in a healthy
sample of middle-aged and elderly females. For this purpose,
we examined the associations of protective psychological
and interpersonal factors, as well as endocrine factors
(sex hormones), with female sexual functioning and its
various components.
MATERIALS AND METHODS
This study was part of the Women 40+ Healthy Aging
Study, a large research project that was conducted at the
Department of Clinical Psychology and Psychotherapy of the
University of Zurich. The goal of the research project was
to investigate healthy middle-aged and older women using a
biopsychosocial framework.
Study Participants and Procedure
In total, 130 self-reporting healthy women aged 40–73 years
participated in the study. The sample was recruited among
the general population using online advertisements and flyers.
Participants’ self-reported health status was used as inclusion
criteria. The participants had to report either a good, very
good, or excellent health condition, and had to state that they
were currently free of any acute or chronic somatic disease
or mental disorder. Furthermore, none of the participants had
received psychotherapy or psychopharmacological treatment
in the previous 6 months. Additional exclusion criteria were
applied regarding the assessment of hormones: pregnancy in
the last 6 months; precocious menopause or menopausal status
due to surgical removal of either both ovaries or the uterus;
current use of oral contraceptives or use of hormone therapy
in the last 6 months; any disease influencing the endocrine
system; current diabetes mellitus, polycystic ovary syndrome,
hirsutism, or endometriosis. Our study population included
women with pre-, peri-, and postmenopausal status. According
to the frequently used classification system Stages of Reproductive
Aging Workshop+10 (Harlow et al., 2012), we considered women
with regular menstrual cycle as premenopausal; women with
variable cycle length or an interval of amenorrhea of >60 days
as perimenopausal; and women without menstrual bleeding in
the last 12 months or more as postmenopausal. As illustrated
in the participant flow chart (Figure 2), 37 women had to be
excluded from the total sample for the data analyses. Most of
these women reported not having had any sexual activity in
the last month, which is a prerequisite for the appropriate use
of the instrument measuring female sexual functioning (Rosen
et al., 2000). Unfortunately, some women showed inconsistencies
when reporting whether they engaged in sexual activity and
therefore had to be excluded. Therefore, the total and final
sample for the present analyses amounted to N = 93 healthy and
sexually active women.
The study procedure consisted of two parts: In a first step,
participants were invited to the laboratory for a physiological
assessment, including the standardized collection of biological
material for the analyses of endocrine parameters. Second, they
completed validated psychosocial questionnaires online. In order
to control for the menstrual cycle phase in premenopausal
women, the physiological and psychosocial assessments were
applied in the follicular phase. Written informed consent was
obtained from all participants prior to data collection. The
Cantonal Ethics Committee (KEK) of the canton of Zurich
and the Cantonal Data Protection Commission of the canton
of Zurich approved the study. The study was conducted in
accordance with the principles of the Declaration of Helsinki.
Psychosocial Measures
Psychosocial measures included protective psychological traits
and interpersonal factors. All psychosocial measures were
assessed online via self-reports using validated questionnaires.
The participants were explicitly informed about the procedure
and expected duration (approximately 30 min) of the online
assessment prior to filling in the questionnaires. It was required
to complete all questionnaires consecutively.
Sexual Functioning
Sexual functioning was examined using the German version of
the Female Sexual Function Index (FSFI; Rosen et al., 2000)
validated by Berner et al. (2004). The FSFI is a multidimensional
self-report instrument and is considered to be the gold standard
for the assessment of female sexual functioning. It contains 19
items covering six key domains of female sexual functioning:
desire, arousal, lubrication, orgasm, satisfaction, and pain. Each
domain comprises two to four items assessing the frequency,
the level (degree) of, and/or satisfaction with the corresponding
sexual functioning domain. Response options varied depending
on the type of item. For items measuring frequency, the response
options ranged from 0 (no sexual activity) to 5 (almost always
or always). Items measuring the level of the specific sexual
functioning domain or the satisfaction with it were either rated as
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FIGURE 2 | Participant flow chart.
0 (no sexual activity) or rated from 1 (very low or none at all/very
dissatisfied) to 5 (very high/very satisfied). To obtain individual
domain scores for each sexual functioning domain, the scores
of the corresponding items were added up and multiplied by
the domain factor. Additionally, a full-scale score (total FSFI
score) was calculated by summing up the six domain scores. Full-
scale scores range from 2 to 36, with higher scores indicating
better overall sexual functioning. According to Wiegel et al.
(2005), women with and without sexual dysfunction can be
discriminated by a total FSFI cutoff value of 26.55. Regarding
the psychometric properties of the German version of the FSFI,
Berner et al. (2004) reported satisfactory results in their validation
study, with internal consistencies for the FSFI domains and total
score ranging from α = 0.75 (satisfaction) to α = 0.95 (pain). In
the present study, we found an excellent internal consistency for
the total FSFI score (Cronbach’s alpha = 0.92) and a range from
α = 0.74 (satisfaction) to α = 0.91 (pain) for the FSFI domains. The
estimated duration to complete the FSFI is approximately 10 min
(Berner et al., 2004).
Protective Psychological Markers
Self-esteem
The Multidimensional Self-Esteem Scale (MSES; Schütz and
Sellin, 2006) was used to assess overall self-esteem. This self-
report scale comprises a total of 32 items rated on a 7-
point Likert scale, which examine six different aspects of self-
esteem: emotional self-esteem, social skills, social confidence,
achievement-related self-esteem, physical attractiveness, and
sportiness. Furthermore, a global self-esteem score can be
computed which includes all dimensions, and for which
satisfactory reliability and validity (Cronbach’s alpha = 0.93)
have been reported (Schütz and Sellin, 2006). This global
score was used in the present study; internal consistency in
the present study was acceptable (Cronbach’s alpha = 0.77).
It takes approximately 10–15 min to complete the MSES
(Schütz and Sellin, 2006).
Optimism
Dispositional optimism was measured with the German version
of the Life Orientation Test-Revised (LOT-R) developed by
Glaesmer et al. (2008). The LOT-R encompasses 10 items (three
items each for optimism and pessimism, four neutral items)
that are rated on a 5-point Likert scale. The item scores are
added up to build an optimism and a pessimism scale. Only the
optimism scale was used in this study. Glaesmer et al. (2008)
reported an internal consistency of α = 0.69 for the optimism
scale. Despite this rather questionable value, the authors argue
that factor analysis clearly supports a two-factor structure and
that the scale is applicable for research purposes. This is also
supported by the short duration required to complete the LOT-R
(approximately 5 min).
Extraversion
The short version of the Big Five Inventory (BFI-K; Rammstedt
and John, 2005) was used to evaluate extraversion. The BFI-
K contains 21 items rated on a 5-point Likert scale and
depicts the Big Five personality traits: extraversion, neuroticism,
conscientiousness, agreeableness, and openness. To build the
trait subscales, the corresponding four to five item scores per
trait are added together. In this study, only the extraversion
subscale was used. Rammstedt and John (2005) reported
satisfactory psychometric properties of the BFI-K, with an
internal consistency ranging between α = 0.81 and 0.86 for the
extraversion scale in different samples. The Cronbach’s alpha of
extraversion in this study lay at 0.79, implying an acceptable
internal consistency. The BFI-K is a particularly economic
instrument, since the average duration to complete all items is
under 2 min (Rammstedt and John, 2005).
Life satisfaction
Participants’ life satisfaction was measured with the most
commonly used instrument in this area, the Satisfaction with Life
Scale (SWLS; Glaesmer et al., 2011). The SWLS comprises five
items rated on a 7-point Likert scale and is completed within few
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minutes. In a German validation study, Glaesmer et al. (2011)
found very good internal consistency for the SWLS (Cronbach’s
alpha = 0.92). Cronbach’s alpha in the present study lay at 0.87.
Interpersonal Factors
Relationship satisfaction
The Relationship Assessment Scale (RAS; Sander and Böcker,
1993) was used to evaluate participants’ satisfaction with
their intimate relationship. The RAS is a brief measure, only
comprising seven items rated on a 5-point Likert scale. Validation
studies found satisfactory results regarding reliability and validity
of the instrument (Sander and Böcker, 1993). In the present
study, the internal consistency of the RAS was excellent, with a
Cronbach’s alpha of 0.91.
Emotional support
Emotional support was assessed using the Berlin Social Support
Scales (BSSS; Schwarzer and Schulz, 2000). The BSSS measures
the level of emotional support, instrumental support, search
for social support, and need for social support using 17 items
rated on a 4-point Likert scale. Only the emotional support
scale was used in this study. The validity and reliability of the
BSSS have been demonstrated in several studies (Schulz and
Schwarzer, 2003). In the present study, Cronbach’s alpha lay at
0.83 for the emotional support scale. Completion of the BSSS
takes approximately 10 min.
Endocrine Measures
Saliva samples as well as capillary blood samples were collected
in order to analyze endocrine parameters. The steroid hormones
estradiol (E2), testosterone (T), progesterone (P4), and DHEA-S
were assessed in saliva. Measurement of these steroids in saliva
samples is well-established and reliable (for review, see Lewis,
2006; Gröschl, 2008). FSH, LH, and SHBG were determined in
dried blood spot (DBS) samples. DBS sampling is an eligible and
valid method to quantify these biomarkers, since highly sensitive
and precise assays exist for the determination of FSH, LH, and
SHBG (Worthman and Stallings, 1997; Edelman et al., 2007;
McDade et al., 2007). Furthermore, DBS sampling is a viable and
effective alternative to blood sampling by venipuncture, because
it is less invasive and expensive, as well as easier to collect and
store (Edelman et al., 2007).
Both saliva and capillary blood samples were obtained under
standardized conditions at 8.00 am in the laboratory of the
Department of Clinical Psychology and Psychotherapy of the
University of Zurich. Prior to the sampling, the participants
answered questions about incidents (e.g., infection or cold in
the last week) and activities (e.g., sleep difficulties and subjective
stress level at that moment) that could potentially have biased the
current hormone concentrations.
Saliva Sampling
Saliva was collected with a SaliCap sampling tube of 2 mL
capacity (IBL International GmbH, Hamburg, Germany).
Participants were instructed to let the saliva flow to the base of
the mouth before drooling into the tube using a polypropylene
straw (passive drool method). Following the collection, saliva
samples were stored at −20◦C. The samples were thawed and
centrifuged prior to biochemical analysis using IBL Saliva
Immunoassays (IBL International GmbH, Hamburg, Germany).
All saliva samples were analyzed in the biochemical laboratory of
the Department of Clinical Psychology and Psychotherapy at the
University of Zurich.
Dried Blood Spot Sampling
For the assessment of steroid hormone concentrations in
dried blood, small capillary blood samples were drawn from
participants’ fingers. A sterile, disposable lancet (Accu-Chek R©
Safe-T-Pro Plus) was used for the finger prick on the middle
finger of the non-dominant hand. Capillary blood drops were
spotted onto standardized filter paper (Whatman R© Protein Saver
Cards, No. 903). The DBS samples were dried for 4 h and then
frozen at−20◦C. All DBS measures were analyzed in the Cytolab
laboratory in Regensdorf, Switzerland.
Statistical Analyses
Statistical analyses were conducted using the Statistical Package
for the Social Sciences (SPSS, version 23). To compare
pre- and postmenopausal women regarding their level of
sexual functioning, a Mann-Whitney U-test (non-parametric
alternative procedure to the independent samples t-test) was
used in order to account for the heteroscedastic variances. In
addition, we calculated a one-way ANOVA (Analysis of Variance)
including age as a covariate, to examine whether differences in
sexual functioning between pre- and postmenopausal women
remain significant when adjusting for age. To examine the
associations between main variables (age, psychosocial factors,
and endocrine factors) and sexual functioning, bivariate and
partial correlation analyses were calculated in a first step. To
further determine the strength of these associations and to test
possible predictors of sexual functioning, simple and multiple
linear regression analyses were conducted in a second step.
In addition, we examined the associations between the main
variables and the dichotomous outcome of sexual functioning
(absence vs. presence of healthy sexual functioning) according
to the FSFI cutoff value of 26.55 proposed by Wiegel et al.
(2005). For that reason, we first used bivariate correlation
analyses to discover significant associations, and subsequently
calculated logistic regression analyses to predict the odds of the
dichotomous outcome. For all analyses testing the associations
of psychosocial factors and sexual functioning, age and BMI
were included as covariates. Additionally, systolic and diastolic
blood pressure, medication intake and smoking status were
statistically considered when testing the associations of steroid
hormones and sexual functioning. Steroid hormone values were
not normally distributed and were therefore log-transformed
prior to the analyses. For all analyses including salivary steroids,
24 participants were excluded from the analyses due to gum
bleeding (N = 2), an infection or injury in the mouth cavity
(N = 3), or having had a cold (N = 19) in the days before the
laboratory assessment. To adjust for multiple testing, we used
the false discovery rate proposed by Benjamini and Hochberg
(1995). The α-value of 0.05 was adjusted by (n+1)/2n, taking
into account seven dependent variables per comparison (six
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FSFI domain scores and total score). Therefore, an α-value
of p < 0.029 was considered statistically significant. For all
analyses testing the associations of the main variables with
the dichotomous outcome of sexual functioning (absence vs.
presence of healthy sexual functioning), the level of statistical
significance was set at α = 0.05.
RESULTS
Sample Characteristics
The final sample consisted of N = 93 healthy middle-aged
and elderly women aged 40–73 years. Table 1 provides the
sociodemographic and health-related sample characteristics.
The vast majority of participants were either pre- or
postmenopausal. Regarding education, a vocational education or
a college/university degree were most frequently reported.
More than half of the sample was married, while the
remaining participants were either single or in a common-
law relationship. All of the participants were either hetero- or
bisexual. About two thirds of the participants had their own
children. The vast majority of the sample neither smoked nor
took any medication.
TABLE 1 | Descriptive statistics of sociodemographic and health-related sample
characteristics (N = 93).
Age, M ± SD 52.5 ± 8.5
Menopausal status, n (%)
Premenopausal 45 (48.4)
Perimenopausal 6 (6.5)
Postmenopausal 42 (45.2)
Education, n (%)
Vocational education 39 (41.9)
High school-leaving certificate 11 (11.9)
College/university degree 37 (39.8)
Other 6 (6.5)
Relationship status, n (%)
Single 10 (10.8)
In a relationship 29 (31.2)
Married 54 (58.1)
Sexual orientation, n (%)
Heterosexual 88 (94.6)
Bisexual 5 (5.4)
BMI (kg/m2), M ± SD 22.71 ± 3.62
Blood pressure (mmHg), M ± SD
Systolic blood pressure 121.77 ± 13.83
Diastolic blood pressure 79.58 ± 8.34
Smoking, n (%)
Yes 12 (12.9)
No 81 (87.1)
Medication, n (%)
Yes∗ 8 (8.6)
No 85 (91.4)
∗Reported medication included antihypertensive drugs, cholesterol-lowering drugs,
dietary supplements or other (acid blockers and gastric protection).
TABLE 2 | Descriptive statistics of sexual function characteristics.
FSFI domain M ± SD MIN, MAX Range
Desire 6.03 ± 1.36 2.00, 10.00 2–10
Arousal 15.96 ± 3.31 5.00, 20.00 0–20
Lubrication 16.82 ± 3.70 5.00, 20.00 0–20
Orgasm 12.45 ± 2.51 5.00, 15.00 0–15
Contentment 13.00 ± 2.28 5.00, 15.00 2–15
Pain 13.55 ± 2.45 2.00, 15.00 0–15
Total sexual functioning 29.05 ± 4.28 13.20, 36.00 2–36
Data are presented as mean (M) ± standard deviation (SD), minimum (MIN),
maximum (MAX) scores, and range. Higher scores in the FSFI domains indicate
better sexual functioning.
Sexual Function Characteristics
Descriptive statistics of sexual function characteristics (total
FSFI and domain scores) are presented in Table 2. Higher
scores in the FSFI domains indicate better sexual functioning.
In our sample, 74 women (79.6%) scored above the cutoff
value proposed by Wiegel et al. (2005), indicating healthy
sexual functioning. As our sample comprised middle-aged
and elderly women (Age: M = 52.5 years, SD = 8.5 years),
we examined the impact of age and menopausal status on
sexual functioning.
Age and Sexual Functioning
Age was negatively associated with arousal (r = −0.302,
p = 0.003), lubrication (r = −0.401, p < 0.001), and overall
sexual functioning (r = −0.283, p = 0.006). These negative
associations were further confirmed using linear regression
analyses. The results demonstrated that the lower the women’s
age, the higher their overall sexual functioning (β = −0.267,
p = 0.010, adj. R2 = 0.61), arousal (β = −0.295, p = 0.004,
adj. R2 = 0.077), and lubrication (β = −0.393, p < 0.001, adj.
R2 = 0.145). Furthermore, age was negatively associated with
having healthy sexual functioning (r = −0.318, p = 0.002).
Binary logistic regression analysis revealed that age [b = −0.094,
Wald(1) = 8.312, p = 0.004] was a significant predictor of having
healthy sexual functioning [Chi-Square(1) = 9.206, p = 0.002].
The odds ratio (OR) for age was 0.911 (95% CI 0.854−0.970),
which means that for one added year of life, the relative
probability to have healthy sexual functioning decreases 8.9% in
the sample. Nagelkerke’s R2 was 0.148.
Menopausal Status and Sexual Functioning
Premenopausal (N = 45) and postmenopausal (N = 42)
women were compared in terms of their sexual functioning.
A Mann-Whitney U-test indicated that arousal was greater
for premenopausal (Mdn = 17.00) than for postmenopausal
(Mdn = 16.00) women (U = 693.000, p = 0.031). The
two groups also differed significantly regarding lubrication
(U = 608.000, p = 0.003), with premenopausal women
having greater lubrication (Mdn = 19.00) than postmenopausal
women (Mdn = 16.00). The significant group differences are
illustrated in Figure 3.
In addition, we analyzed whether the differences in sexual
functioning between pre- and postmenopausal women remained
Frontiers in Psychology | www.frontiersin.org 7 March 2019 | Volume 10 | Article 546
fpsyg-10-00546 March 12, 2019 Time: 10:1 # 8
Mernone et al. Sexual Functioning in Healthy Aging Women
FIGURE 3 | Median values of arousal (A) and lubrication (B) in premenopausal (N = 45) vs. postmenopausal women (N = 42). Arousal and lubrication were
measured using the Female Sexual Function Index (FSFI; Rosen et al., 2000). Significance level: ∗p < 0.05, ∗∗p < 0.01.
significant when adjusting for age. A one-way ANOVA including
age as a covariate revealed that this was not the case.
Associations Between Psychosocial
Factors and Sexual Functioning
To investigate the contribution of protective psychosocial
factors to sexual functioning, we examined relationship-related
factors (relationship satisfaction and emotional support) and
psychological factors (self-esteem, optimism, extraversion, and
life satisfaction) as possible predictors. In a first step, partial
correlations between these psychosocial factors and sexual
functioning were calculated, as illustrated in Table 3. The
associations were further analyzed using regression analyses.
Controlling for age and BMI, linear regression analyses revealed
that overall sexual functioning (total FSFI score) was significantly
predicted by optimism (β = 0.247, p = 0.018, adj. R2 = 0.136),
relationship satisfaction (β = 0.307, p = 0.005, adj. R2 = 0.122), and
emotional support (β = 0.246, p = 0.015, adj. R2 = 0.110). Life
TABLE 3 | Summary of the partial correlation coefficients for the association of
psychosocial factors with sexual functioning (N = 93).
RAS BSSS-ES MSWS LOT-R-O BFI-K-E SWLS
Desire 0.255 −0.012 0.053 0.222 0.105 0.080
Arousal 0.297∗∗ 0.209 0.201 0.253∗ 0.102 0.135
Lubrication 0.124 0.011 –0.019 0.007 –0.002 –0.011
Orgasm 0.041 0.246 0.186 0.274∗∗ 0.168 0.081
Contentment 0.488∗∗∗ 0.379∗∗∗ 0.278∗∗ 0.223 0.218 0.335∗∗
Pain 0.227 0.271∗∗ 0.243 0.125 0.158 0.116
Total sexual
functioning
0.314∗∗ 0.254∗∗ 0.215 0.248∗ 0.169 0.163
Covariates: age, BMI. RAS, relationship satisfaction; BSSS-ES, emotional
support; MSWS, self-esteem; LOTR-O, optimism; BFI-K-E, extraversion; SWLS,
life satisfaction. Significance level: ∗p < 0.029 (adjusted for multiple testing),
∗∗p < 0.01, ∗∗∗p < 0.001.
satisfaction, self-esteem and extraversion were not significant
predictors of overall sexual functioning (all p > 0.029).
The associations between the psychosocial factors and sexual
functioning were further examined regarding the FSFI domains
desire, arousal, lubrication, orgasm, contentment, and pain,
using regression analyses. Optimism (β = 0.251, p = 0.015, adj.
R2 = 0.120) and relationship satisfaction (β = 0.289, p = 0.007,
adj. R2 = 0.126) each predicted arousal. Optimism was also
a significant predictor of orgasm (β = 0.282, p = 0.009, adj.
R2 = 0.064). Sexual contentment was significantly predicted
by the following psychosocial factors: relationship satisfaction
(β = 0.484, p < 0.001, adj. R2 = 0.239), emotional support
(β = 0.370, p < 0.001, adj. R2 = 0.172), self-esteem (β = 0.272,
p = 0.008, adj. R2 = 0.107), and life satisfaction (β = 0.330,
p < 0.001, adj. R2 = 0.141). The domain pain was only predicted
by emotional support (β = 0.271, p = 0.009, adj. R2 = 0.056). None
of the tested psychosocial factors were predictive for the domains
desire and lubrication (all p > 0.029).
In addition, we examined the associations between the
psychosocial factors and the dichotomous outcome of sexual
functioning (absence vs. presence of healthy sexual functioning).
Emotional support was positively associated with having healthy
sexual functioning (r = 0.253, p = 0.015), adjusted for age and
BMI. Binary logistic regression analysis indicated that emotional
support [b = 0.319, Wald(1) = 4.759, p = 0.029] was a significant
predictor of healthy sexual functioning [Chi-Square(3) = 15.447,
p = 0.001]. The OR for emotional support was 1.376 (95 %
CI 1.033 – 1.833), which means that as emotional support
increases one unit, the relative probability to have healthy sexual
functioning increases 37.6%. Nagelkerke’s R2 was 0.240.
Associations Between Endocrine
Factors and Sexual Functioning
As illustrated in Table 4, partial correlation analysis revealed
that overall sexual functioning was not associated with any of
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TABLE 4 | Summary of the partial correlation coefficients for the associations of steroid hormones with sexual functioning (N = 93 for blood steroids, N = 69 for
salivary steroids).
E2 P4 T DHEA-S FSH LH SHBG
Desire 0.132 0.006 0.083 −0.233 −0.235† −0.165 0.084
Arousal 0.055 0.085 0.256† −0.069 −0.077 −0.141 −0.070
Lubrication 0.060 0.023 0.060 −0.158 −0.145 −0.129 0.056
Orgasm 0.057 0.193 0.316∗ 0.033 0.084 0.046 −0.047
Contentment −0.035 −0.019 0.012 −0.207 −0.091 −0.114 −0.046
Pain −0.001 0.103 0.068 −0.084 −0.131 −0.111 −0.006
Total sexual functioning 0.057 0.089 0.176 −0.153 −0.116 −0.136 −0.008
Covariates: age, BMI, systolic and diastolic blood pressure, medication, smoking status. For the salivary steroids, N = 24 participants were excluded due to reports of
a cold, infection, or gum bleeding before the laboratory assessment. E2, estradiol; P4, progesterone; T, testosterone; DHEA-S, dehydroepiandrosterone sulfate; FSH,
follicle-stimulating hormone; LH, luteinizing hormone; SHBG, sex hormone-binding globulin. Significance level: ∗p < 0.029 (adjusted for multiple testing), †p < 0.05.
the tested steroid hormones (adjusted for age, BMI, systolic
and diastolic blood pressure, medication, and smoking status).
When investigating the single FSFI domains and steroid
hormones, testosterone was positively associated with orgasm.
Regression analyses further confirmed that testosterone was
a significant predictor of orgasm (β = 0.329, p = 0.012,
adj. R2 = 0.089).
Additionally, we examined the associations between the
endocrine factors and the dichotomous outcome of sexual
functioning (absence vs. presence of healthy sexual functioning).
Partial correlation analysis (including the covariates) showed
no significant associations with the tested steroid hormones.
Therefore, the endocrine factors were not entered into a binary
logistic regression model.
DISCUSSION
This study investigated psychobiological predictors of sexual
functioning in a healthy sample of middle-aged and elderly
females. For this purpose, we examined the associations
of age, menopausal status, protective psychological and
interpersonal factors, as well as endocrine factors with female
sexual functioning and its various components. First, we
found that age and menopausal status were negatively
associated with the level of sexual functioning in the
sample. Second, psychosocial factors emerged as the key
predictors of sexual functioning. To our knowledge, this
is the first study to test and demonstrate the importance
of optimism and emotional support for healthy women’s
sexual functioning in midlife and older age. Third, we found
that sex hormones were not related to sexual functioning in
this healthy sample.
As our sample comprised middle-aged and elderly women
(40–73 years), it was necessary to take into account age and
menopausal status for the investigation of sexual functioning.
Negative effects of age on female sexual functioning are
frequently reported in the literature and also reflected in
the prevalence rates of sexual dysfunction across different
age ranges (e.g., Nicolosi et al., 2004). However, the findings
differ in terms of which aspects of sexual functioning are
affected by age. In the present study, younger age was
associated with higher levels of arousal, lubrication, and
overall sexual functioning. This is partly consistent with the
existing literature. Most of the previous studies investigated
the effects of age on sexual desire, interest, and frequency
of sexual activity (reviewed in Hayes and Dennerstein, 2005),
with the majority of findings revealing a decrease in sexual
desire and interest (e.g., DeLamater and Sill, 2005). Research
on the effects of age on arousal in females is limited
(Hayes and Dennerstein, 2005). The available studies have
reported both a decline in arousal with increasing age (Lee
et al., 2016) as well as no changes (Cain et al., 2003).
The negative relationship between age and lubrication can
be biologically explained by age-associated changes in the
urogenital system. As women age, vaginal symptoms such
as vaginal dryness emerge more often due to the reduced
production of mucus from the glands of the vaginal wall as
a sign of vaginal atrophy (Samsioe, 1998). However, these
age-associated physiological changes are confounded by the
hormonal effects of the menopausal transition phase, and
therefore need to be carefully disentangled from the effect of
menopausal status on sexual functioning (Dennerstein et al.,
2001). In our study, however, we found that menopausal
status was only related to sexual functioning independently of
age. Finally, the high correlation between sexual arousal and
lubrication (as one of the main physiological underpinnings
of arousal) may explain why both of these aspects are
associated with age.
Regarding the relevance of menopausal status for sexual
functioning, we found that pre- and postmenopausal women only
differed in their level of sexual arousal and lubrication. Overall
sexual functioning differed only at a trend level (p < 0.10).
These findings are only partly consistent with the literature.
According to various longitudinal studies, the transition to
menopause is related to some, but not necessarily all, aspects
of sexual functioning. For example, Avis et al. (2000) found
a lower level of sexual desire and arousal with advancing
menopausal status, while other aspects of sexual functioning
remained unrelated to menopausal status. In another study,
lubrication emerged as the domain of sexual functioning
with the most pronounced decline during the transition to
menopause (Gracia et al., 2007). Other findings revealed that
pain during sexual intercourse increases, while only sexual desire
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decreases across the menopausal transition (Avis et al., 2009).
These inconsistencies might be due to methodological issues
concerning the differing measurement of sexual functioning or
the dependency of sexual functioning on other factors besides
age and menopausal status, such as psychosocial factors in
midlife and older age.
In the present study, we found several psychosocial predictors
of sexual functioning. A high level of relationship satisfaction
and emotional support were associated with better overall
sexual functioning in this healthy sample. The importance of
relationship-related factors for sexual health in midlife and
older age has already been discussed in the literature (Brotto
et al., 2016). In line with previous research findings, relationship
satisfaction seems to be among the most important determinants
of female sexual functioning (Dennerstein et al., 2005; Thomas
and Thurston, 2016). Our results provide additional evidence
for the importance of relationship satisfaction, because it
was a predictor not only of sexual contentment, but also of
arousal and overall sexual functioning. The partner plays a
key role for a woman’s satisfying sexuality, since the partner’s
sexual functioning may have an impact on the females’ sexual
functioning (DeLamater and Karraker, 2009). There is evidence
showing a strong correlation between females’ and males’ sexual
functioning (Yeoh et al., 2014). Therefore, one’s own sexual
wellbeing may not only be dependent on the satisfaction with
the relationship, but also on the partner’s sexual wellbeing.
However, social support, and in particular emotional support,
had not been previously investigated. Interestingly, our study
showed that emotional support was a predictor of overall
sexual functioning as well as of particular aspects, namely
sexual contentment and pain. Moreover, to our knowledge, the
present study was the first to examine the role of optimism
for the sexual functioning of healthy middle-aged and elderly
females. Optimism is defined as a personality disposition
characterized by generalized positive outcome expectancies,
and has been shown to be positively associated with physical
health and mental well-being (Carver and Scheier, 2014).
We found that a higher level of optimism was related to a
higher level of overall sexual functioning, arousal, and orgasm.
Furthermore, life satisfaction and self-esteem were associated
with sexual contentment in our study, but not with overall
sexual functioning. We assume that life satisfaction may be
specifically connected to satisfaction in other areas of life,
such as sexuality, which would explain the association with
sexual contentment. Self-esteem represents a central dimension
of the self-concept, which has been shown to have health-
promoting effects on a variety of outcomes regarding, for
example, emotion, cognition, and motivation (Goodson et al.,
2006). So far, the relationship between self-esteem and sexual
functioning has not been investigated in detail. Our results
are partly in line with a study showing that collegiate women
with higher self-esteem reported greater sexual contentment
and orgasmic response (Rehbein-Narvaez et al., 2006). However,
there is a lack of studies including women in middle and
older age. Finally, it is interesting to note that none of the
tested psychosocial factors in this study were related to sexual
desire or lubrication. Further research is needed to confirm our
findings and to examine psychosocial factors associated with
desire and lubrication.
As part of the biopsychosocial approach, we also examined
the role of endocrine factors in the sexual functioning of
healthy females. None of the tested endocrine parameters (E2,
T, DHEAS, P, FSH, LH, and SHBG) were linked to overall
sexual functioning. This argues against the assumption that
sex steroids are important for female sexual functioning due
to their age- and menopause-associated fluctuations (Clayton
and Harsh, 2016). From that perspective, it is surprising that
sex steroids were not associated with sexual functioning in
our sample of pre- and postmenopausal women. From yet
another perspective, however, our findings are in line with the
majority of current studies and overviews pointing to weak
or no correlations between sex steroids and female sexual
functioning (Meston and Frohlich, 2000; Dennerstein et al.,
2005; Wierman et al., 2010; Randolph et al., 2015; Worsley
et al., 2016). An explanation for the observed results in this
study may lie in the rather low variability across our study
sample. All of our participants reported to be physically and
mentally healthy, did not take any hormonal agents and reported
rather low levels of menopausal symptoms, which may indicate
an adaptive adjustment to hormonal fluctuations. Taking this
into account, we can speculate that endocrine factors might
only be determinants of sexual dysfunction rather than sexual
function. Additional research is required to test this hypothesis
and to further examine the contribution of sex steroids to
women’s overall sexual functioning in midlife and older age.
Another potential explanation for the non-significant findings
may concern the validity of the saliva samples for the hormones
measured in our elderly sample. Although the assessment of
E2 in saliva samples is valid and salivary E2 is considered as
an adequate estimate of serum E2 (Fiers et al., 2017), there
is data suggesting that salivary E2 may only predict serum
E2 among postmenopausal women who use estrogen therapy
(Tivis et al., 2005). According to the authors, E2 levels may
be too low among postmenopausal women who do not use
estrogen therapy and therefore cannot be adequately detected via
saliva samples.
However, we found that a specific aspect of sexual functioning,
namely orgasm, was positively associated with the level of
testosterone. Testosterone is the sex steroid which is assumed to
primarily influence sexual desire and motivation (Bachmann and
Leiblum, 2004; Wåhlin-Jacobsen et al., 2015). Evidence for the
importance of testosterone in female sexual functioning mainly
stems from studies demonstrating that testosterone replacement
therapy improves sexual functioning (Shifren et al., 2000;
Goldstat et al., 2003). Pharmacological agents such as testosterone
or Flibanserin, a 5-hydroxytryptamine 5-HT1A agonist and 5-
HT2A antagonist, are frequently reviewed as treatment options
for poor sexual desire and low sexual functioning in mostly
premenopausal women (Roslan et al., 2019; Simon et al., 2019).
However, their efficacy and safety is the subject of controversial
discussion in the current literature.
The present study has several strengths. First, it is one
of the few studies to investigate exclusively healthy females
in midlife and older age. Strict inclusion criteria ensured
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that the examined women were physically and mentally
healthy, and did not take any hormone replacement or
psychotropic medication. Second, we applied a biopsychosocial
health approach and therefore included various perspectives,
examining biological, psychological, and interpersonal factors
of the complex phenomenon of female sexual functioning.
Furthermore, we focused on positive and protective factors
in relation to optimal sexual functioning, which have
rarely been investigated so far. This notion is in line
with positive health concepts that stress the importance
of strengths and resources rather than risks and pathology
(Graugaard, 2017).
Some limitations of the present study should also be
acknowledged. The Women 40+ Healthy Aging Study has a
cross-sectional design, in which psychosocial and hormonal data
were gathered at only one time point. Therefore, it was not
possible to infer causality of the tested associations. Further,
larger studies are required to confirm our results. Additionally,
future longitudinal examinations are needed to examine changes
in sexual health and functioning over time and the associated
psychobiological factors. In particular, multiple measurements of
endocrine parameters over time would be preferable in order
to account for intraindividual hormonal fluctuation, which is
especially relevant in the investigation of sex hormones in
pre- and perimenopausal women. Furthermore, the use of
saliva and DBS samples to measure sex hormones in middle-
aged and elderly women needs to be carefully validated in
future studies. Although the quantification of the mentioned
hormones in saliva and DBS samples is a reliable approach and
has several advantages, it may also be inferior to measuring
serum levels in some samples or subgroups like postmenopausal
women (see Tivis et al., 2005). Another limitation refers to
the assessment of sexual functioning and the associated sample
size reduction in our study. The FSFI (Rosen et al., 2000)
is considered to be the gold standard in the assessment of
female sexual functioning and is broadly used in clinical and
epidemiological research. Due to its dependence on sexual
activity, women with no engagement in sexual activity over the
last 4 weeks had to be excluded from the study. According to
Rosen et al. (2000), the FSFI should only be applied to women
who have had sexual activity during the measurement period.
From a total of 130 women participating in the Women 40+
Healthy Aging Study, 13 participants reported not having been
sexually active in this time frame. Unfortunately, 14 more study
participants showed inconsistencies when reporting whether
they engaged in sexual activity in the last month and therefore
also had to be excluded. For most of the FSFI items, it was
possible to select “no sexual activity” as a response option,
leading to within-subject inconsistencies across different items
in terms of the reported sexual (in-)activity in these women.
We can only speculate about possible reasons for this response
behavior. We did not find any differences between the women
who responded inconsistently and the rest of the sample with
regard to health variables or relationship status. However, it is
interesting to note that for several of the women concerned,
sexual activity was reported primarily at the beginning of
the questionnaire and sexual inactivity toward the end. This
may be due to the occurrence of partner-related questions
toward the end (e.g., item number 14: “Over the past 4 weeks,
how satisfied have you been with the amount of emotional
closeness during sexual activity between you and your partner?”).
Possible explanations are that some of the women did not
want to answer sexual partner-related questions or that the
instructions of the questionnaire regarding the definition of
sexual activity had not been understood correctly. Alternatively,
the inconsistent response behavior may be due to a potential
unwillingness to answer some of the questions for reasons
of privacy or non-disclosure. Thus, our results are important
in that they demonstrate that sexuality is still a rather taboo
topic that may be regarded with shame in some middle-aged
and older women.
Some practical implications may be derived from our findings.
The relevance of psychosocial factors such as social support
or self-esteem for female sexuality in midlife and older age
suggests potential starting points from which to foster sexual
functioning. Psychotherapeutic strategies targeting the social
context, self-concept or aspects of personality may help to
optimize women’s sexual functioning in aging. Furthermore,
in clinical practice, the complete assessment of biopsychosocial
aspects contributing to sexual functioning is necessary in
order to guide the management of middle-aged and older
adult’s sexual health.
In conclusion, this study showed that sexual functioning
in healthy middle-aged and older women is highly dependent
on psychosocial aspects that are health-promoting or related
to well-being, such as interpersonal factors and protective
psychological traits. Endocrine factors seem to be of secondary
importance in this regard. To further investigate female sexual
health and its associated psychobiological underpinnings, a
focus on sexual function rather than dysfunction may be the
better approach.
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